Glucagon-like peptide-1 receptor agonists, also known as GLP-1 analogs, GLP-1RAs, or incretin mimetics, are a class of anorectic drugs that reduce blood sugar and energy intake by activating the GLP-1 receptor. From Wikipedia
She aims to leverage her media revenue skills to expand eMed’s platform that claims to halve care costs for GLP-1 treatments
